Before taking the entrepreneur route, Markus Rinecker was member of the executive board of Definiens AG, an AstraZeneca company, between 2009 and 2019. As CFO he has secured capital for growth and guided Definiens’ integration with AstraZeneca after its acquisition in 2014. Later Markus Rinecker acted as Chief Strategy and Corporate Development Officer and played a key role in shaping and communicating the strategic intent of Definiens.
Prior to joining Definiens, his experience has spanned the founding of a new department for open heart surgery as Managing Director at one of the leading surgical hospitals in Munich to the start-up establishment of Europe’s first full clinical proton radiation center for cancer therapy. For the hospital chain Humaine Kliniken GmbH he evaluated potential acquisition targets and participated in multiple share deal transactions.
Markus Rinecker holds a Doctoral Degree in Medicine at the Ludwig-Maximilians-University in Munich as well as a Master’s Degree in Business Administration of INSEAD, France and Singapore.